Affiliation:
1. The Republican Specialized Scientific and Practical Medical Center for Therapy and Medical Rehabilitation
Abstract
It has been shown that in patients with GERD and functional dyspepsia, the use of proton pump inhibitors leads to a decrease in heartburn and pain behind the sternum. However, symptoms such as regurgitation, belching, feeling of early satiety and heaviness after eating were stopped ineffectively. The inclusion in the treatment complex of the prokinetic domperidone at a dose of 10 mg 3 times a day contributed to a more effective regression of symptoms of impaired motility of the esophagus and stomach.
Publisher
LLC Global Media Technology
Subject
Gastroenterology,Hepatology
Reference9 articles.
1. de Bortoli N., Martinucci I., Bellini M., Savarino E., Savarino V., Blandizzi C., Marchi S. Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol. 2013 Sep 21;19(35):5787-97. doi: 10.3748/wjg.v19.i35.5787.
2. Domperidone IND Packet US Food and Drug Administration. 2018. 17 p. Available at: https: //www.fda.gov/downloads/drugs/development_approval_process/how_drugs_are_developed_and_approved/appro Access 05.05.2021.
3. Drossman D. Rome III: The functional gastrointestinal disorders. 3rd ed. McLean, VA: Degnon Associates, Inc., 2006, pp. 369-418.
4. Keohane J., Quigley E. M. Functional dyspepsia and nonerosive reflux disease: clinical interactions and their implications. MedGenMed. 2007 Aug 8;9(3):31. PMID: 18092037
5. Ortiz A., Cooper C. J., Alvarez A., Gomez Y., Sarosiek I., McCallum R. W. Cardiovascular safety profile and clinical experience with high-dose domperidone therapy for nausea and vomiting. Am J Med Sci. 2015 May;349(5):421-4. doi: 10.1097/MAJ.0000000000000439.